Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

被引:9
|
作者
John, Alexius [1 ,2 ]
Spain, Lavinia [2 ]
Hamid, Anis A. [1 ,2 ,3 ,4 ]
机构
[1] Eastern Hlth, Dept Med Oncol, Melbourne, Vic 3128, Australia
[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3128, Australia
[4] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia
关键词
non-clear cell; renal cell carcinoma; papillary; hereditary leiomyomatosis and renal cell cancer; chromophobe; medullary; collecting duct; COMPREHENSIVE MOLECULAR CHARACTERIZATION; OPEN-LABEL; PHASE-II; SUNITINIB; CABOZANTINIB; EPIDEMIOLOGY; MULTICENTER; MONOTHERAPY; EXPRESSION; CRIZOTINIB;
D O I
10.3390/curroncol30010070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date, clinical trials evaluating the use of immunotherapies and targeted therapies have predominantly been conducted in patients with clear cell histology. A comprehensive review of the literature has been undertaken in order to describe molecular pathogenic mechanisms pertaining to each nccRCC subtype, and concisely summarise findings from therapeutic trials conducted in the nccRCC space.
引用
收藏
页码:923 / 937
页数:15
相关论文
共 50 条
  • [41] Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non-Clear Cell Renal Cell Carcinoma
    Rodriguez Faba, Oscar
    Breda, Alberto
    Rosales, Antonio
    Palou, Joan
    Algaba, Ferran
    Maroto Rey, Pablo
    Villavicencio, Humberto
    EUROPEAN UROLOGY, 2010, 58 (02) : 307 - 310
  • [42] The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma.
    Dai, Jindong
    Hu, Xu
    Zhang, Haoran
    Zhang, Yaowen
    Zhang, Xingming
    Sun, Guangxi
    Zeng, Hao
    Shen, Pengfei
    Liu, Zhenhua
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [43] Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022
    Benjamin L. Maughan
    Current Oncology Reports, 2022, 24 : 1201 - 1208
  • [44] Adjuvant Therapy for Non-Clear Cell Renal Cell Carcinoma-The Ascent Continues
    Brown, Jacqueline T.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [45] Coinhibitory molecule expression and lymphocytic infiltration in non-clear cell renal cell carcinoma
    Roth, Timothy J.
    Hoffmann, Nathan E.
    Thompson, R. Houston
    Lohse, Christine M.
    Kuntz, Susan M.
    Leibovich, Bradley C.
    Blute, Michael L.
    Sheinin, Yuri
    Kwon, Eugene D.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 134 - 135
  • [46] Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022
    Maughan, Benjamin L.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (09) : 1201 - 1208
  • [47] Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma
    Rabinowitz, Matthew J.
    Esfandiary, Tina
    Cheaib, Joseph
    Patel, Sunil H.
    Alam, Ridwan
    Metcalf, Meredith
    Enikeev, Dmitry
    Pierorazio, Phillip M.
    Ged, Yasser M. A.
    Allaf, Mohamad E.
    Singla, Nirmish
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 43 : 28 - 34
  • [48] Loss of PBRMI and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma
    Ho, Thai H.
    Kapur, Payal
    Joseph, Richard W.
    Serie, Daniel J.
    Eckel-Passow, Jeanette E.
    Parasramka, Mansi
    Cheville, John C.
    Wu, Kevin J.
    Frenkel, Eugene
    Rakheja, Dinesh
    Stefanius, Karoliina
    Brugarolas, James
    Parker, Alexander S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 23.e9 - 23.e14
  • [49] Immune landscape of patients with metastatic non-clear cell renal cell carcinoma (nccRCC) treated with atezolizumab plus bevacizumab.
    Saliby, Renee Maria
    El Zarif, Talal
    Bakouny, Ziad
    Xie, Wanling
    Flippot, Ronan
    Denize, Thomas
    Shah, Valisha
    Kane, Harry
    Madsen, Katrine
    Harshman, Lauren C.
    Vaishampayan, Ulka N.
    McDermott, David F.
    Lee, Gwo-Shu Mary
    Xu, Wenxin
    Van Allen, Eliezer Mendel
    McGregor, Bradley Alexander
    Signoretti, Sabina
    Choueiri, Toni K.
    McKay, Rana R.
    Braun, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
    An, Josiah
    Packiam, Vignesh T.
    Chennamadhavuni, Adithya
    Richards, Jordan
    Jain, Jayanshu
    Mott, Sarah L.
    Garje, Rohan
    FRONTIERS IN ONCOLOGY, 2022, 11